These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Curcumin improves TNBS-induced colitis in rats by inhibiting IL-27 expression via the TLR4/NF-κB signaling pathway. Zeng Z; Zhan L; Liao H; Chen L; Lv X Planta Med; 2013 Jan; 79(2):102-9. PubMed ID: 23250811 [TBL] [Abstract][Full Text] [Related]
28. Antidiarrheal and intestinal antiinflammatory activities of a methanolic extract of Qualea parviflora Mart. in experimental models. Mazzolin LP; Kiguti LR; da Maia EO; Fernandes LT; da Rocha LR; Vilegas W; Pupo AS; Di Stasi LC; Hiruma-Lima CA J Ethnopharmacol; 2013 Dec; 150(3):1016-23. PubMed ID: 24157378 [TBL] [Abstract][Full Text] [Related]
29. Beneficial effects of N-acetylcysteine on acetic acid-induced colitis in rats. Cetinkaya A; Bulbuloglu E; Kurutas EB; Ciralik H; Kantarceken B; Buyukbese MA Tohoku J Exp Med; 2005 Jun; 206(2):131-9. PubMed ID: 15888969 [TBL] [Abstract][Full Text] [Related]
30. Analgesic and Anti-Inflammatory Effects of 1% Topical Cannabidiol Gel in Animal Models. Bunman S; Muengtaweepongsa S; Piyayotai D; Charlermroj R; Kanjana K; Kaew-Amdee S; Makornwattana M; Kim S Cannabis Cannabinoid Res; 2024 Jun; 9(3):740-750. PubMed ID: 37669453 [No Abstract] [Full Text] [Related]
31. Halofuginone, a specific inhibitor of collagen type 1 synthesis, ameliorates oxidant colonic damage in rats with experimental colitis. Karakoyun B; Yüksel M; Ercan F; Salva E; Işik I; Yeğen BC Dig Dis Sci; 2010 Mar; 55(3):607-16. PubMed ID: 19390970 [TBL] [Abstract][Full Text] [Related]
32. Assessment of anticolitic drugs in the trinitrobenzene sulfonic acid (TNBS) rat model of inflammatory bowel disease. Whittle BJ; Cavicchi M; Lamarque D Methods Mol Biol; 2003; 225():209-22. PubMed ID: 12769490 [No Abstract] [Full Text] [Related]
33. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. Daniel C; Sartory NA; Zahn N; Radeke HH; Stein JM J Pharmacol Exp Ther; 2008 Jan; 324(1):23-33. PubMed ID: 17911375 [TBL] [Abstract][Full Text] [Related]
34. Timosaponin AIII and its metabolite sarsasapogenin ameliorate colitis in mice by inhibiting NF-κB and MAPK activation and restoring Th17/Treg cell balance. Lim SM; Jeong JJ; Kang GD; Kim KA; Choi HS; Kim DH Int Immunopharmacol; 2015 Apr; 25(2):493-503. PubMed ID: 25698557 [TBL] [Abstract][Full Text] [Related]
35. N-(3-(aminomethyl)benzyl)acetamidine, an inducible nitric oxide synthase inhibitor, decreases colonic inflammation induced by trinitrobenzene sulphonic acid in rats. Menchén LA; Colón AL; Moro MA; Leza JC; Lizasoain I; Menchén P; Alvarez E; Lorenzo P Life Sci; 2001 Jun; 69(4):479-91. PubMed ID: 11459438 [TBL] [Abstract][Full Text] [Related]
36. Inhibitory effects of Geijigajakyak-Tang on trinitrobenzene sulfonic acid-induced colitis. Lee JY; Kang HS; Park BE; Moon HJ; Sim SS; Kim CJ J Ethnopharmacol; 2009 Nov; 126(2):244-51. PubMed ID: 19716872 [TBL] [Abstract][Full Text] [Related]
37. An Orally Active Pagano E; Capasso R; Piscitelli F; Romano B; Parisi OA; Finizio S; Lauritano A; Marzo VD; Izzo AA; Borrelli F Front Pharmacol; 2016; 7():341. PubMed ID: 27757083 [TBL] [Abstract][Full Text] [Related]
38. Treatment with Obestatin-A Ghrelin Gene-Encoded Peptide-Reduces the Severity of Experimental Colitis Evoked by Trinitrobenzene Sulfonic Acid. Konarska K; Cieszkowski J; Warzecha Z; Ceranowicz P; Chmura A; Kuśnierz-Cabala B; Gałązka K; Kowalczyk P; Miskiewicz A; Konturek TJ; Pędziwiatr M; Dembiński A Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29865176 [TBL] [Abstract][Full Text] [Related]
39. Colon-targeted delivery of piceatannol enhances anti-colitic effects of the natural product: potential molecular mechanisms for therapeutic enhancement. Yum S; Jeong S; Lee S; Nam J; Kim W; Yoo JW; Kim MS; Lee BL; Jung Y Drug Des Devel Ther; 2015; 9():4247-58. PubMed ID: 26273188 [TBL] [Abstract][Full Text] [Related]
40. The effect of the cholinergic anti-inflammatory pathway on experimental colitis. Bai A; Guo Y; Lu N Scand J Immunol; 2007 Nov; 66(5):538-45. PubMed ID: 17953529 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]